The Next Big Brain Cancer Drug Could Come from Marijuana

Sy Mukherjee 9:44 PM Central GW Pharmaceuticals (gwph, +2.63%) is already well on its way to winning the first-ever U.S. approval for a cannabis-derived therapy. But an early trial suggests that these treatments could also be an effective way to fight one of most devastating forms of brain cancers: glioblastoma multiforme. The U.K.-based company unveiled …

Advertisements

Hemp Industries Association Sues DEA For Ignoring 9th Circuit Decision in HIA v. DEA (& Please sign this petition for Hemp)

Hemp Industries Association Sues DEA For Ignoring 9th Circuit Decision in HIA v. DEA In 2001, the DEA issued new rules to ban hemp foods despite the fact that Congress had exempted them in the Controlled Substances Act. The HIA, Dr. Bronner's, Nutiva and other plaintiffs went to the 9th Circuit Court of Appeals to …